UPDATE: Section 122 tariff (10%) in effect since Feb 24 — expires ~July 24 (~126 days). 24 states challenge in court (March 5). USTR launches new Section 301 probes (March 11). EU trade deal vote imminent. Full analysis →

HTS 3001 — Glands, organs, and other animal substances for therapeutic use Tariff Rate (2026)

Glands, organs, and extracts thereof, and heparin and its salts for therapeutic or prophylactic uses.

Duty Rates

Free

MFN Rate

10%

Section 122

N/A

Section 232

N/A

Section 301 (China)

Top Countries of Origin

Products classified under HTS 3001 — Glands, organs, and other animal substances for therapeutic use — are among the globally sourced imports entering the US. Glands, organs, and extracts thereof, and heparin and its salts for therapeutic or prophylactic uses. All imports under this heading are subject to the 10% Section 122 tariff (effective February 24, 2026). The top countries of origin for HTS 3001 imports include CN, DE, NZ, AR, DK. Tariff rates vary by source country based on applicable trade agreements and special tariff programs.

Frequently Asked Questions

What is the tariff rate for HTS 3001 (Glands, organs, and other animal substances for therapeutic use)?

The MFN duty rate for HTS 3001 is Free. All imports also face the 10% Section 122 tariff.

Where do most HTS 3001 imports come from?

The top origin countries for glands, organs, and other animal substances for therapeutic use are CN, DE, NZ, AR, DK. Tariff rates vary based on the source country's trade agreements and applicable surcharges.

Will the tariff on HTS 3001 change in 2026?

The 10% Section 122 tariff expires approximately July 24, 2026 unless Congress acts. MFN rates and Section 232/301 tariffs have no set expiration. Monitor legislative and executive actions for changes.